Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Core symptoms in breast cancer chemotherapy remain stable, aiding targeted interventions.

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

Some early breast cancer patients have long-term hair loss after chemotherapy, especially older and postmenopausal women.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Understanding specific symptoms in different cancer stages can improve personalized care and quality of life.

Financial support and better counseling are needed to make chemotherapy more affordable and manageable for women in Pakistan.

Nephronectin is linked to worse outcomes in breast cancer and helps cancer spread.

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.

Glibenclamide slows breast cancer cell growth by stopping cell division.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

Wedelolactone may help prevent bone damage in breast cancer by blocking certain cell signals.

Chinese herbal medicine might help reduce chemotherapy side effects in breast cancer patients, but more high-quality research is needed.

Targeting androgen receptors shows promise for treating triple-negative breast cancer, but more research is needed.

Hair from breast cancer patients shows changes in structure and composition, and a test using these changes detected cancer but also falsely identified some healthy samples as cancerous.

Reduced sexual drive may be linked to male breast cancer, while anti-estrogenic factors might lower the risk.

X-ray diffraction of hair might help detect breast cancer non-invasively.

GnRH treatment can reduce breast cancer cell invasion.

ADCs can effectively treat breast cancer but may cause side effects like nausea and hair loss.

Hair loss can occur as a side effect of certain breast cancer treatments, but minoxidil can help regrow hair.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Mitochondrial genes help predict breast cancer outcomes and spread.

High calcium levels in hair may indicate early breast cancer.

Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

Minoxidil and ranolazine together can reduce the spread of certain breast cancer cells.

Electric pulse treatments for breast cancer show promise in being safer and more effective, with fewer side effects.

The conclusion is that thorough investigation of hypertension and hormonal dysfunctions is important, and there may be a link between these conditions and cancer.

The paper concludes that breast cancer treatment involves complex interactions between medical symptoms, patient experiences, and commercial influences, requiring a holistic approach.

Cold Atmospheric Plasma shows promise in treating aggressive breast cancer by targeting cancer cells while sparing normal tissue.